qps global capabilities presentation
Post on 20-Aug-2015
1.491 Views
Preview:
TRANSCRIPT
BioanalysisThat Way
Navigating Drug Development
ToxicologyThis Way
Early Stage ClinicalThis Way
Translational MedicineThat Way
Phase II – IV ClinicalThis Way
DMPKThat Way
NeuropharmacologyThis Way
Introduction
How do we introduce ourselves to you?
Corporate Mission, Vision of Success & ValuesHistoryBrief Company Overview Global PresenceQPS’ Linearly Integrated Core Competencies:
NeuropharmacologyDMPK ToxicologyBioanalytical Translational MedicineEarly Stage Clinical Development Phase II - IV Clinical Development
Why QPS?
April 18, 2023 Confidential 3
Corporate Mission, Vision of Success & Values
Mission
To accelerate the development of medicines worldwide
by enabling cost effective breakthroughs in pharmaceutical innovation
April 18, 2023 Confidential 4
QPS is a global leader in contract research.We are known for our quality, technical expertise, efficiency, and customer focus.Our passionate and productive work creates value for patients and customers while creating opportunities for employees to grow and thrive.
Corporate Mission, Vision of Success & Values
Vision of Success
April 18, 2023 Confidential 5
Corporate Mission, Vision of Success & Values
Values
Integrity – We make and keep promises and build trust through honesty, proactive communication, and reliability.Quality – We bring the highest level of technical expertise and judgment to our work.Customer Focus – We tap our global resources to provide service that is fast, flexible, and integrated.Commitment – We work hard to solve problems and deliver results. People – We treat people with dignity, respect, and fairness, and embrace our differences.Culture - We are friendly and fun. We provide opportunities to grow, we value loyalty and teamwork, and we recognize and reward performance.
April 18, 2023 Confidential 6
Core Competencies:NeuropharmacologyDMPK (Discovery → Development)ToxicologyBioanalysis (Small Molecules → Biologics & Biosimilars) Translational Medicine (Genetic → Protein Biomarkers)Early Stage Clinical Development (Phase 0 → Phase IIa)Phase II - IV Clinical Development (Phase IIb → Phase IV)
Strategically located sites (1000+ employees) in North America, Europe & Asia
‘QPS offers breadth and depth, plus seamless
integrated service from drug discovery to regulatory
submission’
‘QPS is a global service provider to the pharmaceutical,
biotechnology and generic industries’
Brief Corporate Overview
April 18, 2023 Confidential 8
QPS’ Linearly Integrated Core Competencies
Discovery/Candidate-Selection StageNeuropharmacology, ADME and Tolerability Studies to support Drug Discovery
Preclinical/Non-clinical Development StageAnimal Toxicology studies to support regulatory filingDevelopment DMPK studies to support regulatory filingRegulated Bioanalysis to support animal toxicology studiesImmunogenicity for PD and safety assessmentBiomarkers for animal pharmacology studiesPK/TK modeling
Clinical Development StagePhase I Healthy Volunteer studiesPhase II to IV Patient studiesDevelopment DMPK studies to support NDA filingRegulated Bioanalysis to support clinical studiesImmunogenicity for efficacy and safety monitoringPGx for patient stratification and efficacy monitoringBiomarkers for efficacy and safety monitoring Clinical PK/PD modeling
‘Have it all done in one place. Saves you time. Saves
you resources. Saves you money.’
Since it is a long way (…navigating your way….) to
the bedside’
April 18, 2023 Confidential 10
Slide Deck Navigator
Navigate me directly to….
Global Neuropharmacology ServicesGlobal DMPK ServicesGlobal Toxicology ServicesGlobal Bioanalytical ServicesGlobal Translational Medicine ServicesGlobal Early Stage Clinical Development ServicesGlobal Phase II - IV Clinical Development ServicesWhy QPS?
April 18, 2023 Confidential 11
‘helping you navigate your way through the screening and lead profiling
of your CNS drug candidates’
NEUROPHARMACOLOGY
April 18, 2023 Confidential 12
Global Neuropharmacology Services
Brief Global Overview‘Neuropharmacology services on the basis of scientific excellence and international quality standards’
In Vitro Neuropharmacology ProfilingNeuronal Tissue CultureMode of ActionFull Safety Package
In Vivo Neuropharmacology ProfilingTransgenic and Non-transgenic Rats and MiceGeneration / Phenotyping of new Transgenic Rat and Mouse StrainsScreening for EfficacyLead ProfilingMolecular Biology, Biochemistry, Histology and BioanalyticsFull Safety Package
April 18, 2023 Confidential 13
Global Neuropharmacology Services
In Vitro Cell Culture‘In Vitro Cell Culture facilities equipped with the latest leading edge technologies’
Key Competences (non-exhaustive list)Isolation and Cultivation of Primary Rat/Mouse Neurons (Cortex, Hippocampus, TH-Neurons and Microglia)Isolation and Cultivation of Primary Chicken Cortical Neurons Cultivation of Cell Lines (SHSY-5Y, PC12, BV-2, HMO6, human fibroblasts and ARPE-19)Transfection (Over-expression, Knock Down) of Cell Lines (or Primary Cells)Functional Screening of Test Compounds in different Cell Culture Systems In VitroImmunofluorescence Analysis
April 18, 2023 Confidential 14
Global Neuropharmacology Services
In Vitro Cell Culture‘Screening for efficacious lead drug candidates with a special focus on Neuroprotection’
Key Deliverables (non-exhaustive list)In vitro lesion models (MPP+, BSO, L-glutamate, Aβ1-42 a.s.o.) for AD, PD, Ischemia, AMDOxidative stress and mitochondrial activity Characterization of disease models in vitro (read outs: viability, apoptosis, necrosis and mitochondrial activity)Neurite outgrowth assay (primary hippocampal neurons, image based analysis)In vitro inflammation assays (cytokines, NO release)Screening for secretase and phosphorylation inhibitorsScreening for acetylcholine and butyrylcholine esteraseinhibitors
April 18, 2023 Confidential 15
Global Neuropharmacology Services
In Vivo Animal Models‘High quality and cost effective lead profiling’
Key Competences (non-exhaustive list)BreedingNon-transgenic Mice and Rat Models
MPTP (acute and chronic) induced Parkinson's disease MK-801-induced psychosisForced swim test (depression)Scopolamine induced learning or memory recall impairments 6-OHDA induced injury of dopaminergic neurons
Transgenic Mice and Rat ModelsAll relevant transgenic models for Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) research availableVarious genetically modified animal models: FTD, Amyotrophic Lateral Sclerosis, Niemann Pick Disease and Huntington’s DiseaseCross-breds of the different strains form complete models of human disease
April 18, 2023 Confidential 16
Global Neuropharmacology Services
In Vivo Animal Models‘Unique combination of in house characterized transgenic disease models with the most advanced pharmacological readouts’
Key Deliverables (non-exhaustive list)Acute and Chronic treatment via all common routes but also intrathecal injection and infusions, Alzet™ osmotic mini pumps with and without brain kit a.s.o.Behavioral Test Data (over 20 paradigms):
General Health and Motor Ability; Learning and Memory; Anxiety, Depression;Social Behavior, Attention and other Tests
Molecular Biology DataBiochemistry DataHistology Data
April 18, 2023 Confidential 17
Global Neuropharmacology Services
Molecular Biology‘Our validated protocols for molecular biological assays allow for quantitative evaluations which fulfill the strictest guidelines’
Genetic TestingGeneration of Expression Vectors for Transgenic AnimalsGeneration of Stably Transfected Cell-linesGeneration of Transgenic MiceGenotyping of Transgenic Animals by Quantitative PCRAnalysis of Gene Expression by RT-PCRQuantification of Virus Particles by PCRSafety Monitoring for Gene Therapy
April 18, 2023 Confidential 18
Global Neuropharmacology Services
Biochemistry‘Our GLP certified laboratory is ready to analyze all types of neurological biomarkers’
Bioanalysis in human blood or CSF samplesAmyloid beta, tau and phospho-tau, alpha SynucleinInflammation markerEnzyme activity: Cholinesterase, Monoaminooxidase and MyeloperoxidaseOxidative stressCholesterolAnalysis of disease related markers in brain, CSF, blood of Tg animal models; Assay Techniques:
ELISAWestern BlotMesoscale Discovery Multiplex AssaysEnzymatic assaysAmorfix Aggregated Aβ Assay A4(exclusively at QPS)
April 18, 2023 Confidential 19
Global Neuropharmacology Services
Histology‘World-class quantitative histopathology services backed by a highly dedicated team of histology, pathology, neurobiology and image analysis experts’
HistotechniquesAccording to principles of uniform, systematic random samplingVibratome, cryotome or slide microtomes
ImmunohistochemistryStandard stainings (e.g. H&E, Nissl, Congo Red, ThioS, Silver Stains)Antibody testing (specificity, sensitivity)Development of customer based multiple labelings (mainly fluorescent)> 400 primary and secondary antibodies on stock
Imaging on fully automatized microscopes High throughput multichannel mosaic imagingZ-stacking for high magnificationLarge data storage
QuantificationsAutomated and semi-automated measurementsTotal comprehensibility of obtained data to imagesCustomized quantification procedures and feasibility analyses
April 18, 2023 Confidential 20
Slide Deck Navigator
Navigate me directly to….
Global Neuropharmacology ServicesGlobal DMPK ServicesGlobal Toxicology ServicesGlobal Bioanalytical ServicesGlobal Translational Medicine ServicesGlobal Early Stage Clinical Development ServicesGlobal Phase II - IV Clinical Development ServicesWhy QPS?
April 18, 2023 Confidential 21
‘helping you navigate your way through the biotransformation of your drug’
DMPK
April 18, 2023 Confidential 22
Global DMPK Services
Brief Global Overview‘DMPK services include the necessary studies for regulatory filing at the appropriate time and mechanistic studies when required’
PharmacokineticsSingle and Multiple Dose, Dose Proportionality, Absolute Bioavailability, PK/TK ModelingMass Balance/Excretion/Radiolabel StudiesFormulation Optimization, Intestinal Permeability, other Mechanistic Studies
Protein Binding; RBC/Plasma Distribution PartitioningProtein Covalent Binding
Tissue DistributionDiscovery QWBAQuantitative Whole-Body Autoradiography (QWBA)Micro-autoradiography (MARG)
MetabolismMetabolic Stability, Species ComparisonCYP450 Inhibition/InductionMetabolic Reaction Pathway ProfilingMetabolite Profiling & Identification – In Vitro, Preclinical, and Clinical
Rat PK 3-in-1 IV/PO
1
10
100
1000
10000
0 4 8 12 16 20 24
Comp'd #1(IV)Comp'd #1 (PO)Comp'd #2 (IV)Comp'd #2 (PO)Comp'd #3 (IV)Comp'd #3 (PO)
April 18, 2023 Confidential 23
Global DMPK Services
Brief Global Overview‘QPS staff's experience is our biggest asset’
Team of senior DMPK scientists that all have on average 15+ years of pharmaceutical and biotech drug discovery and development experience.
All were DMPK representatives on discovery and/or development teams.Worked on > 50 INDs and > 10 NDAs.Worked in different therapeutic areas (Antiviral, CV, Oncology, etc.)The same group of scientists also has on average additional 10+ yrs of CRO experience.
Scientific Integrity and QualityEach DMPK management team member has in-depth skill sets in different fields:
Formulation & AbsorptionPharmacokinetics & Protein BindingQWBA & Micro-autoradiographyMetabolismMetabolite Identification
Program Development ConsultingAddress routine and mechanistic ADME issuesADME Summary for Regulatory Submission
April 18, 2023 Confidential 24
Global DMPK Services
Discovery ADME Studies‘QPS performs cost effective discovery ADME screens’
Metabolic stabilityCYP inhibition
“Validated” process with FDA approved specific probe substrates and chemical inhibitors
Protein bindingEquilibrium dialysis using conventional device or RED or HT96
Rodent PK – linearly integratedFormulationIn-life – Discrete or “N-in-1” dosingBioanalysis method development & sample analysis
“N-in-1” bioanalysis
PK calculationAverage turnaround time < 7.5 days from compound receipt to reporting of data
April 18, 2023 Confidential 25
Global DMPK Services
Candidate Selection Studies‘QPS experienced staff knows how to select your best IND candidates’
PharmacokineticsFormulation, dose proportionalityIntestinal permeabilityOther mechanistic studies for absorption and disposition (or clearance)
MetabolismSpecies comparison Metabolite profiling and/or identificationPilot CYP mapping
ExcretionRoute of elimination – BDC studies
Bile Duct-Cannulated Studies using 3H-labeled Compounds
0
10
20
30
40
50
60
70
80
90
100
110
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 55 57 59
# of Study
% D
ose
Re
cove
red
Cage Wash
Feces
Urine
Bile
Average Recovery 87.4%
Bile Duct-Cannulated Studies using 3H-labeled Compounds
0
10
20
30
40
50
60
70
80
90
100
110
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 55 57 59
# of Study
% D
ose
Re
cove
red
Cage Wash
Feces
Urine
Bile
Average Recovery 87.4%
April 18, 2023 Confidential 26
Global DMPK Services
Radiolabeled Studies‘QPS has proven innovative study design and executional excellence for radiolabeled studies’
Combination Mass Balance /Excretion QWBA study to address MB, tissue distribution, and human radiation dosimetry questions
Better technical oversightEliminate the possibility of radiolabel degrading over an extended period of time between the two studies and the requirement of re-purificationIncrease efficiency using a single study protocol = ↓Study Cost
Metabolite Profiling and Identification in the same studyBoth ion trap and quadrupoles tandem mass spectrometers for different MSn experiments
Mass Balance Excretion Studies in Rats using 14C-labeled Cpds
0
10
20
30
40
50
60
70
80
90
100
110
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45
# of Studies
% D
ose
Re
co
ve
re
d
Carcass
Air
Cage Wash
Feces
Urine
Bile
Average Recovery 93.8%
April 18, 2023 Confidential 27
Global DMPK Services
QPS Delaware DMPK Facility‘DMPK function with all necessary equipment and self-contained for speed’
Vivarium – focus on mouse and rat with nine (9) rodent rooms1 Surgical SuiteTriple cannulated animals for special models & in situ CSFIntracranial infusions for up to 7 days
Eight (8) bioanalytical labs for dose formulation, sample preparation, and analysisMass Balance Studies
Mass Balance Cages (Plastic and Glass)Micro-Filter Cages for Mice, Nude Mice and Rats
In Vitro cell culture LabS9, microsomes, and hepatocytesTumor cell-lines for xenografts
LIMSDEBRA and Watson
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
IV PO PO/BDCPe
rcen
t Dos
e R
ecov
ered Rinse
Urine
Bile
Feces
April 18, 2023 Confidential 28
Global DMPK Services
QPS Delaware DMPK Facility‘DMPK function with all necessary equipment and self-contained for speed’
Two (2) Autoradiography Labs for Macro- and Micro-autoradiographyLeica CM 3600 Cryomacrotome (whole-body)Leica Vibratome 9800 (whole-body)Leica CM 3050 S Cryomicrotome (individual organ/tissue)Molecular Dynamics Typhoon 9410 ImagerSix (6) Imaging Research MCID Elite Systems
Support Equipment: • Snap-freezing Equipment• Photography Equipment• Sample Oxidizers • Liquid Scintillation / Gamma Counters• Microplate Scintillation Counter• Radioactivity / LC Detectors
April 18, 2023 Confidential 29
Global DMPK Services
QPS Delaware DMPK Facility‘DMPK function with all necessary equipment and self-contained for speed’
Dedicated LC/MS/MSThree (3) bioanalytical labs for sample preparation and analysisSix (6) Mass Spec (5 Sciex API 4000s, Finnigan LTQ ProteomeX)Waters UPLCs, Shimadzu VP-series LCs, Agilent 1100 LCs; LEAP HTC/PAL injectorsDetectors – UV/Vis, Fluorescence, ElectrochemicalTomtec Quadra 96 for 96-well sample preparation
Radio-QuantitationTwo (2) Packard Model 307 Sample OxidizersTwo (2) PE Tri-Carb 2800TR/2900TR Scintillation CountersPE TopCount® NXT Microplate Scintillation CounterPackard Cobra II Gamma CounterFour (4) Radioactivity DetectorsARC XFlow System; Off-line Fraction Collectors
April 18, 2023 Confidential 30
Global DMPK Services
QPS Delaware DMPK Facility‘DMPK function with all necessary accreditation, certifications, permits, and licenses’
AAALAC AccreditationABC LicenseCDC Permit DEA Permit for Scheduled Control Substances (I-V)Federal Fish & Wildlife PermitNRC License for Radiochemicals
3H, 14C, 32P, 33P, 35S, 45Ca, 51Cr, 90Y, 99mTc, 111In, 125I, 188ReOLAW AssuranceORCA CertificationUSDA Permit
April 18, 2023 Confidential 31
Slide Deck Navigator
Navigate me directly to….
Global Neuropharmacology ServicesGlobal DMPK ServicesGlobal Toxicology ServicesGlobal Bioanalytical ServicesGlobal Translational Medicine ServicesGlobal Early Stage Clinical Development ServicesGlobal Phase II - IV Clinical Development ServicesWhy QPS?
April 18, 2023 Confidential 32
‘helping you navigate your way through the safety of your drug’
Toxicology
April 18, 2023 Confidential 33
Global Toxicology Services
Brief Global Overview‘QPS CTPS Taiwan is one of the most experienced toxicology centers in Asia’
Track RecordOver 1000 GLP Studies conducted since 1997 17 dossiers compiled for US FDA IND submission18 dossiers compiled for Taiwan IND submission
Accreditations & Compliance:AAALAC Accreditation since 2000Taiwan Accreditation Foundation (TAF) ISO 17025Taiwan Department of Health (DOH) GLPOECD (TAF) GLPUS FDA GLP compliance
April 18, 2023 Confidential 34
Global Toxicology Services
Safety Evaluations‘QPS CTPS is able to provide you the complete battery of toxicological tests that is needed for the filing of your IND submission’
General & Reproductive ToxicologyGenetic Toxicology General (non-GLP) Toxicity TestingPharmacokinetics with BioanalysisBiocompatibility TestingTopical Toxicity Testing
April 18, 2023 Confidential 35
Global Toxicology Services
General & Reproductive Toxicology‘QPS CTPS is able to provide you with a comprehensive package of in vivo toxicology studies’
Single Dose Toxicity StudiesRepeat Dose Toxicity Studies
Up to 6 months in durationRoutes of administration: oral, intravenous (injection and infusion), intramuscular, subcutaneous, intraperitoneal and othersAnimal species: mice, rats, guinea pigs, hamsters, rabbits, dogs ……….and cynomolgus monkeys coming soon!
Reproductive ToxicologyFertilityTeratologyAnimal species: rat and rabbit
Clinical PathologyUrine AnalysisHematologySerum Chemistry
HistopathologyTissue and Slide PreparationTissue ImageQA of Scanned Slides, Pathology Consultation and Evaluation by US Board-Certified Pathologist
April 18, 2023 Confidential 36
Global Toxicology Services
Genetic Toxicology‘QPS CTPS is able to provide you a broad panel of in-house conducted genotoxicity tests’
Gene Mutation AssaysAmes Test/Mini-Ames TestHPRT gene mutation assayIn Vitro mouse lymphoma assay
Cytogenetic AssaysSister chromatid exchange assayChromosome aberration assay
Micronucleus AssaysMicronucleus assay in CHO cells and
human peripheral lymphocytesMouse micronucleus assay
Cell Transformation AssayIn Vitro cell transformation assay
April 18, 2023 Confidential 37
Global Toxicology Services
Biocompatibility Testing‘QPS CTPS is able to provide you with this high-quality niche service which primarily involves the toxicity testing of medical devices’
Acute Systemic Toxicity TestPyrogen and LAL Test
Animal species: rabbitIntracutaneous Irritation TestSkin Sensitization TestCytotoxicity TestIn Vitro HemolysisMutagenicity TestImplantation Test
April 18, 2023 Confidential 38
Global Toxicology Services
Topical Toxicity Testing‘QPS CTPS is able to provide you with other high-quality niche services which primarily involves the toxicity testing of dermatological and cosmetic products’
Irritation StudiesEye irritation testDermal irritation testAnimal species: rabbit
Skin Sensitization TestingBuehler testMaximization testAnimal species: guinea pig
April 18, 2023 Confidential 39
Global Toxicology Services
Why QPS for Toxicology‘QPS CTPS Taiwan supports you with a quality operation for the highest value ’
US owned, 15-year US GLP study history (1997 - present)Highly experienced toxicologists, US, EU and Japan trained (DABT, DJST)Highly experienced QA, registered with SQALarge/small molecule, device development expertiseOn-site clinical pathology, histopathology by DACVP, dose analysis, bioanalyticalEstablished global procedures for sample shipping and data analysisRemote video study monitoring Gold standard animal sourcing (Charles River; Marshall Beijing)State of the art automatic data collection system (Xybion Pristima®)Considerable price savings versus US site labs
April 18, 2023 Confidential 40
Slide Deck Navigator
Navigate me directly to….
Global Neuropharmacology ServicesGlobal DMPK ServicesGlobal Toxicology ServicesGlobal Bioanalytical ServicesGlobal Translational Medicine ServicesGlobal Early Stage Clinical Development ServicesGlobal Phase II - IV Clinical Development ServicesWhy QPS?
April 18, 2023 Confidential 41
‘helping you navigate your way through the measurement of your drug’
Bioanalytical
April 18, 2023 Confidential 42
Global Bioanalytical Services
Brief Global Overview‘QPS is a global leader in bioanalysis for both small and large molecules’
Small molecules – using mass spectrometric techniquesLarge Molecules - using ligand binding assay techniquesGlobal coverage of bioanalytical services with local presence in North America, Europe, India and AsiaWorld leading…
Specialists (> 150 technical staff)State-of-the-art equipment (API5500Q, API 5000, UPLC-MS/MS, ICP-MS, MSD6000 and Gyros™)Capacity (> 45 Mass Specs)Capabilities: LC-MS/MS, ICP-MS, LC-UV, LC-Flu, LC-ECD, LC-RFD, LBA, Hybridization-ELISA and RIA
Extensive validated assay list (> 800 assays and growing)Rapid assay development, validation, sample analysisSupporting a full range of development from Preclinical to Late Stage Clinical programsImmunogenicity & Neutralizing Antibody Activity AssessmentCentral Lab Services: Sample Logistics / Sample Repository / Preparation and Distribution of Sampling Kits
April 18, 2023 Confidential 43
Global Bioanalytical Services
Small Molecule LC-MS/MS‘QPS is a global leader in bioanalysis
for small molecules and is able to analyze samples coming from
different types of studies, containing a wide variety of compound
structures and biological matrices’
Bioanalytical Method Development & Validation Sample Analysis for different evaluation purposes:
Pharmacokinetic (PK) screeningToxicokinetic (TK) studiesClinical PK/Bioavailability studiesBioequivalency studiesTherapeutic drug monitoring studiesBiomarker studiesDrug-drug interaction studies
Sample Analysis of different compound structures:
Oligonucleotides AnalysisPeptide Analysis
Sample Analysis in different biological matrices:
Dried Blood SpotsTissues
April 18, 2023 Confidential 44
Global Bioanalytical Services
Large Molecule ImmunoBioanalysis
‘QPS is a global leader in bioanalysis for large molecules and is able to analyze
samples coming from different types of studies, containing a wide variety of compound structures and biological
matrices’
Bioanalytical Method Development & Validation for Biologics and BiosimilarsSample Analysis for different evaluation purposes:
Pharmacokinetic (PK) screening Toxicokinetic (TK) studiesPK/Bioavailability studiesBioequivalency studiesTherapeutic drug monitoring studiesBiomarker studiesDrug-drug interaction studies
Immunogenicity monitoring using four-tier approach:
ScreeningConfirmatory (immunodepletion) Titer assessment (quantification)Cell-based neutralizing antibody detection
April 18, 2023 Confidential 45
Global Bioanalytical Services
‘QPS is an experienced provider of GLP trace and ultra-trace elemental analysis in preclinical and clinical studies by (LC)-ICP-MS. Applications range from quantitative, high throughput analysis (700 samples/day) to qualitative, stability or metabolite profiling studies .
Sample matrices are blood, plasma, urine, feces, tissue or formulation. Examples of routine applications at QPS using ICP-MS in drug development studies are:
Total and free Platinum (Pt) in oncology studies
Platinum (Pt) in plasma and urine by LC-ICP-MS for the metabolite profiling of a new platinum compounds
Gadolinium (Gd) in plasma and urine by ICP-MS supporting clinical studies with MRI contrast agents and formulations
Magnesium (Mg), Calcium (Ca), and Phosphate (P) in food and feces for supporting a mass balance study of a new phosphate binder
Ag, Zn, Al, Pd, Gd, Tc, I, P, S, Mn, Co. Ni, Se, Cu, As, Si and Eu in different biological or pharmaceutical matrices
Fe in Transferrin Co in Vitamin B12
04/18/2023 Confidential 46
Elemental Analysis in Drug Development
Global Bioanalytical Services
Large Molecule LC-MS/MS‘QPS believes strongly in this novel
bioanalytical application of LC-MS/MS and can show you some
stunning results’
Bioanalytical Method Development and Validation, and Sample Analysis
OligonucleotidesPeptidesProteinsMonoclonal Antibodies
April 18, 2023 Confidential 47
Global Bioanalytical Services
QPS Delaware GLP Facility – Newark, Delaware, USA‘QPS Delaware is a well-established high quality, cost-effective sourcing solution for the analysis of PK and PD samples coming from preclinical and clinical studies conducted in the USA’
Small Molecule LC/MS/MS29 (25 Sciex API 4000 and 4 Sciex API 5000)
Large Molecule ImmunoBioanalysisCapability in PK, Immunogenicity, NAb assay, and biomarkersVarious technology platforms: ELISA, MSD ECL, GYROS and RIA
Hundreds of validated methods (DDI CoMeds) availableComplete list available on website (www.qps.com)WATSON LIMS System v7.4.1 with Immune Response Module(IRM)
April 18, 2023
Gyrolab™ Automated Immunoassay Workstation
Confidential 48
Global Bioanalytical Services
QPS Netherlands GLP Facility – Groningen, the Netherlands‘QPS Netherlands is a well established high quality, cost-effective sourcing solution for the analysis of PK and PD samples coming from preclinical and clinical studies conducted in Europe’
Small Molecule LC/MS/MS8 Triple Quadrupoles Mass Spec (API 5500Q, 4000, 3000)
Large Molecule ImmunoBioanalysisCapability in PK, Immunogenicity, NAb assay, and Biomarkers
Elemental Spectrometry (ICP-MS)ICP-MS; total analysis, product testing, free and protein bound, e.g., Pt for oncology LC-ICP-MS; speciation, metabolite identification, stability/degradation studiesUV-Vis Spectrometry, determination of radioactive labeled compounds
Hundreds of validated assay methods (DDI CoMeds) availableComplete list available on website (www.qps.com)Logistically closely linked to the phase I unit to enable fast turnaround of plasma concentration data of laboratory biomarkers and drug candidates during the conduct of first-in man programs (SAD, MAD), human mass balance and microdosing studies, and trials with instable compounds
24 July 2012 Confidential 49
Global Bioanalytical Services
QPS Bioserve GLP Facility – Hyderabad, India‘QPS-Bioserve is a high quality, cost-effective sourcing solution for the analysis of PK samples coming from bioequivalence studies conducted by QPS-Bioserve’s own phase I Unit and from clinical studies performed in India’
Small Molecule LC/MS/MS7 Triple Quadrupoles Mass Spec (2 Sciex API 3200 and 5 Sciex API 4000)
Hundreds of generic methods availableComplete list available on website www.qps.comQPS-Bioserve has a dedicated and experienced Pharmacokinetics & Statistics team, with expertise in the application and presentation of PK and statistical principles, critical for successful approval of generic product submissions:
Study design, sample size and statistical power estimationBioequivalence analysisPK and PK/ PD analysisIn Vitro - In Vivo Correlation (with Pharsight™ IVIVC toolkit software)WinNonlin™ for PK analysis and SAS for statistical analysisFinal Report submissions in E3/ CTD format
April 18, 2023 Confidential 50
Global Bioanalytical Services
QPS Taiwan GLP Facility – Taipei, Taiwan‘QPS-Taiwan is a high quality, cost-effective sourcing solution for the analysis of PK samples coming from bioequivalence studies conducted by QPS-Bioserve’s own Phase I Unit and from clinical studies performed in Asia’
Small Molecule LC/MS/MS4 Triple Quadrupoles Mass Spec (4 Sciex API 4000)
Large Molecule ImmunoBioanalysisCapability in PK, Immunogenicity, Nab Assay, and Biomarkers
Hundreds of generic methods availableComplete list available on website (www.qps.com)WATSON LIMS System v 6.4 (WATSON v7.4.1 Coming Soon!)
April 18, 2023 Confidential 51
Slide Deck Navigator
Navigate me directly to….
Global Neuropharmacology ServicesGlobal DMPK ServicesGlobal Toxicology ServicesGlobal Bioanalytical ServicesGlobal Translational Medicine ServicesGlobal Early Stage Clinical Development ServicesGlobal Phase II - IV Clinical Development ServicesWhy QPS?
April 18, 2023 Confidential 52
‘helping you navigate your way through the efficacy of your drug’
Translational Medicine
April 18, 2023 Confidential 53
Global TLM Services
Brief Global Overview‘As an experienced provider of translational medicine services, QPS offers solutions to help guide drug development teams at various stages, including patient stratification, toxicity prediction, evaluation of PK profiles, dose determination, and treatment decisions’
BiomarkersPD protein or biochemical markersVarious biomarker assay platforms (ELISA, Immulite®, Bioplex®, MSD® Imager 6000 ECL, GYROS, Flow Cytometry, LC-MS/MS and LC-ECD) Cell-based & functional assaysWestern Blot analysis & quantificationRadioligand binding assayOn-site cell stimulation and cytokine biomarker panel evaluation
Pharmacogenomics (PGx)DNA & RNA isolation and banking Genotyping (SNPs, insertions, deletions, copy numbers, etc.)CpG methylation quantificationRNA isolation & expression profiling (qRT-PCR)
April 18, 2023 Confidential 54
Global TLM Services
Biomarker Panels‘QPS offers laboratory biomarker panels for many different therapeutic areas’
Adrenal/Pituitary Disorders Diabetes/Lipid Metabolism/ Carbohydrate Metabolism
Reproductive Endocrinology
Allergy Gastrointestinal Thyroid Function
Alzheimer’s Disease Hemostasis/Angiogenesis
Anemia Infectious Disease
Autoimmune Disease Inflammation/Immune Status/Cell Response
Bone Disease / Metabolism Oncology (Tumor/Neoplasia Markers)
Cardiac Markers Phenotypic Markers of Drug Metabolism
Cell Response Renal Toxicity and Function
April 18, 2023 Confidential 55
Global TLM Services
Pharmacogenomics (PGx)‘Genotyping and gene expression analysis services are offered by QPS to help ‘individualize’ disease therapies’
Nucleic Acids Isolation (DNA & RNA) and BankingGenotyping (SNPs, Insertions, Deletions, Copy numbers, etc.) CYP450 Genotyping Assays (CYP2B6, CYP3A4, CYP3A5, CYP2C9, CYP2C19, CYP2D6 genotyping panels)Genotyping Assays for Other Drug Metabolizing Enzymes (NAT1, NAT2, UGT1A1, CDA)Genotying Assays for Transporters (ABCG2, SLCO1B1)Genotyping Assays for Oncology (BRAF, KRAS, PIK3CA) Genotyping Assays for Alzheimer’s Disease (ApoE, PPP3R1)Genotyping Assays for Warfarin Therapy (CYP2C9*2, CYP2C9*3, and VKORC1 (-1639 G>A))CpG Methylation QuantGene Expression Profiling in various matrices (qRT-PCR)
Pyrosequencing
1300
1400
1500
1600
1700
1800
1900
2000
2100
E S C G A C G T G T C T G
T/T
5 10
April 18, 2023 Confidential 56
Global TLM Services
Immunogenicity/Anti-Drug Antibody Testing‘QPS is an expert in immunogenicity/ADA & Nab testing and has all the necessary knowledge and assays technologies at its disposal’
QPS has supported 50+ biologic drug development programs for 23 sponsors (24 proteins and 26 therapeutic antibodies) for which over 120 studies were performed.Anti-Drug-Antibodies (Screening, Confirmation, and Titering) by ELISA or MSD ECLAntibody Generation Critical Reagent LabelingCell Based Neutralizing Antibody (NAb) Assays Cell Banking and MaintenanceTechnology Transfer Custom Method Development and Optimization
Meso Scale DiscoveryApril 18, 2023 Confidential 57
Global TLM Services
Neutralizing Antibody Assays‘QPS is an expert in NAb testing and is able to apply its extensive knowledge and application of new assay technologies to your benefit’
Since 2002 > 50 Studies conducted for 7 Sponsors ELISACell-Based Functional Assays, e.g. cell viability assayOther Functional Assays, e.g. activity assay Receptor Binding Assays
April 18, 2023 Confidential 58
Global TLM Services
Novel Biomarker Assay Development‘QPS is a frontrunner in adopting new assay technologies for biomarkers’
Various Technology Platforms (ELISA, BioPlex™, Immulite™, MSD ECL, Gyrolab™ and BD FACS Canto II)Cell-Based AssaysPharmacodynamic (PD) & Safety MarkersMultiplexing Genetic Markers (CYP450 TaqMan or Affymetrix DMET genechips)Pharmacodynamic (PD) Assays On-Site Cell Stimulation and Biomarker AnalysisFit-For-Purpose Biomarker Assay Development and Validation (various matrices)Protocol Design
Standard Curves from Custom 6-Plex Cytokine Assay
Concentration, pg/mL
1 10 100 1000 10000
signa
l
0
5000
10000
15000
20000
25000
IL-1ßIL-2IL-4TNF-aIL-6INF-g
Luminex™
April 18, 2023 Confidential 59
Global TLM Services
Analytical Platforms‘QPS scientists and laboratory technicians are used to work and have many validated assays on many different assay technology platforms’
ELISA Pyrosequencing Technology Platform
Roche Modular P® Affymetrix GeneChip Microarray System
Siemens Immulite® TaqMan Real-Time PCR System
Bioplex® (Luminex™) Gradient Gel Electrophoresis (GGE)
Meso Scale Discovery (MSD®) ECL Platform (SECTOR™ PR100 and Imager 6000)
HPLC/UHPLC/UV/Fluorescence/ECD
Gyrolab™ LC – MS/MSBD FACS Canto II® Ultracentrifugation
RIA Western Blot Analysis
Radioligand Binding Assay (SPA)
April 18, 2023 Confidential 60
Slide Deck Navigator
Navigate me directly to….
Global Neuropharmacology ServicesGlobal DMPK ServicesGlobal Toxicology ServicesGlobal Bioanalytical ServicesGlobal Translational Medicine ServicesGlobal Early Stage Clinical Development ServicesGlobal Phase II - IV Clinical Development ServicesWhy QPS?
April 18, 2023 Confidential 61
‘helping you navigate your way through the complex challenges of the early
development of your drug’
Global Early Stage Clinical Research
April 18, 2023 Confidential 62
Global Early Stage Clinical Research
Brief Global Overview‘QPS is a global leader in Phase I/IIa studies’
QPS has one of the world’s largest Phase 1 site offerings with almost 500 Phase I beds on three continents:
QPS offers a complete spectrum of early phase study types:
April 18, 2023 Confidential 64
240 in Springfield, Missouri, USA 75 in South Miami, Florida, USA 20 in Hollywood, Florida, USA 92 in Hyderabad, India40 in Taipei, Taiwan 58 in Groningen, The Netherlands
First-in-Man Programs (SAD + MAD + FE + CYP450) Human Mass Balance studies Microdosing studies Imaging (PET, fMRI) studiesClinical PK/PD studies Drug-Drug Interaction studiesCardiac Safety/Thorough QT/QTc studies Bioavailability/Bioequivalence/ANDA studiesVaccine studies Specialty PopulationsProof-of-Concept (PoC) in multiple therapeutic areas
Global Early Stage Clinical Research
Biomarker Support‘QPS is not only capable of conducting phase 1 studies for you in specialty and patient populations but QPS is also capable of doing the additional measurement and interpretation of therapeutic-specific biomarker data as well’Adrenal / Pituitary Disorders Diabetes / Lipid
Metabolism / Carbohydrate Metabolism
Reproductive Endocrinology
Allergy / Asthma / COPD Gastrointestinal Thyroid FunctionAlzheimer’s Disease Hemostasis / Angiogenesis
Anemia Infectious Disease
Autoimmune Disease Inflammation / Immune Status / Cell Response
Bone Disease / Metabolism Oncology (Tumor / Neoplasia Markers)
Cardiac Markers Phenotypic Markers of Drug Metabolism
Cell Response Renal Toxicity and Function
April 18, 2023 Confidential 65
Global Early Stage Clinical Research
Full-Service Early Stage CRO ‘QPS is a full service early stage CRO that is not only capable of providing the clinical conduct of your Phase 1 study but has the ability to provide the front and back end services as well’
Review of Preclinical DataDesign and Preparation of the TrialClinical Project ManagementPreparation of the Study Protocol, Informed Consent, and Case Report FormsClinical ConductClinical Data ManagementBiostatisticsBioanalysis/Biomarker AssaysConduct PK/PD and/or Pop PK/PD DataAnalysis and ModelingPrepare PK/PD ReportPrepare and Publish Fully IntegratedClinical Study ReportsMonitoringPharmacovigilance
April 18, 2023 Confidential 66
Global Early Stage Clinical Research
QPS Bio-Kinetic – Springfield, Missouri, USA‘QPS Bio-Kinetic is ideally suited to conduct a wide variety of phase I studies, especially when substantial numbers of volunteers need to be recruited in record breaking time’
5 Clinical Units with 240 beds on one CampusOver 1000 studies completed since 199417 FDA InspectionsClinical Staff Experience
8+ years average length of employmentLess than 3% staff turnover rate
37,000 subjects in database Specialty Studies
VaccinePostmenopausalGeriatricBirth Control and Birth Control NaïveCardiac Safety/TQTc
April 18, 2023 Confidential 67
Global Early Stage Clinical Research
QPS MRA – South Miami, Florida, USA‘QPS MRA conducts complex phase I studies that other sites are unable to execute’
16,000 Square Feet facility50 actively monitored bedsUnique high-level medical oversightHealthy volunteers (FIM, SAD, MAD), specialty populations, and Proof-of-Concept (PoC) in multiple therapeutic areasConsistent high enroller, often exceeding contracted subject allocationExcellent subject retention (over 90%)
April 18, 2023 Confidential 68
Specialty & PoC PopulationsElderly ObesityHepatic Insufficiency Parkinson’sRenal Insufficiency DepressionPsoriasis Pediatric ADHDType II Diabetes Arthritis
RheumatoidOsteoarthritis
Post-Menopausal LupusHypertension On Demand
Global Early Stage Clinical Research
QPS Broward – Hollywood, Florida, USA‘QPS Broward is an experienced Phase I site with a great track record in reliable and efficient study conduct’
BRG established in 2000 – 10,000 sq. ft. facilityDavid Seiden, MD – Board-Certified in Sleep, Neurology, and PsychiatryHealthy Volunteers/Special Populations – Sleep, Vaccines, Depression, Anxiety, ADHD, Birth Control, T2DM, Obesity, Parkinson's, Alzheimer's, OA etc…Over 150 Clinical Trials completed – Phase I-IVBRG Facility
20 beds 15 ACRP-Certified Coordinators, Nurse Practitioner, Neuropsychologist, RN’s, LPN’s, Sleep TechniciansQA / Regulatory deptsLaboratory, EEG, ECG, pulse oximetry recording equipment, polysomnography, refrigerators, centrifuge, freezers (-20 C and -70 C)
April 18, 2023 Confidential 69
Global Early Stage Clinical Research
QPS Bioserve – Hyderabad, India‘QPS Bioserve is a full service Phase I site with a long list of regulatory approvals for generic products that have been tested at this site’
Full-service CRO, all aspects of study (from study design to final report generation) are conducted in-houseISO 9001:2008 certified organizationApproved by the Drugs Controller General of India (DCGI)Audited by the US-FDA in March 2008 & July 2009 (no 483s)Inspected by UK MHRA and WHO in 2010Over 630 conventional BA/BE studies conducted for variousregulatory agencies (130 are pivotal studies)Twenty (20) products successfully approved by US FDAClinical End Point Studies: QPS Bioserve has experience in using PD end points or other acceptable surrogate parameters to establish bioequivalence for products (e.g. locally acting/topical preparations) for which it is impossible to use PK endpoints.Examples: Sucralfate (suspension), Pentosan Polysulfate (capsules), Adapalene (gel)Pharmacoscintigraphic ImagingNCE PK studies like Food Effect, Dose Proportionality and Drug-Drug Interaction
April 18, 2023 Confidential 70
Global Early Stage Clinical Research
QPS Taiwan – Taipei, Taiwan‘QPS Taiwan is a full service Phase I site with a long list of regulatory approvals for locally manufactured generic products’.
Full-service CRO, all aspects of study (from study design to final report generation) are conducted in-houseBioavailability / Bioequivalence StudiesHealthy Normal PopulationsPK in Cancer Patient PopulationsScaled Average BioequivalenceConventional BA/BE studies conducted for various regulatory agenciesMore than 40 products successfully approved by Taiwan FDA
April 18, 2023 Confidential 71
Global Early Stage Clinical Research
QPS Netherlands – Groningen, the Netherlands‘QPS Netherlands is ideally suited to conduct your FIM and more complex phase I programs’
Hospital-based Phase I unit Over 100 studies completed: 20 first-in-man programs (of which 12 with biologics); 7 PET studies; 6 Oral Contraceptive (OC) interaction studiesFast and easy access to top-notch medical, clinical-pharmacological, medical and scientific expertiseParallel submission to Competent Authority (CCMO) and local Ethics Committee (EC) resulting in Clinical Trial Approval within 14 days. Substantial amendments: 48h turnaround time; Dose escalations: 24h turnaround timeLogistically closely linked to the bioanalytical laboratory to enable fast turnaround of plasma concentration data of laboratory biomarkers and drug candidatesSpecialty Studies:
April 18, 2023 Confidential 72
Multi-Purpose Umbrella Protocols (SAD + MAD + food effect + CYP450 phenotyping) - adaptive designs with flexible dosing escalation schemes
Female Health Care (OC Interaction, Lactation and Fertility studies)Validated neuropathic (capsaicin) and acute (M3 extraction)pain models
Pulmonary/Respiratory MedicineImaging (PET, fMRI) studiesContinuous) CSF sampling in Healthy Volunteers and (Alzheimer) Patients(Radiolabel (14C) Human Microdosing and Mass Balance studies
Slide Deck Navigator
Navigate me directly to….
Global Neuropharmacology ServicesGlobal DMPK ServicesGlobal Toxicology ServicesGlobal Bioanalytical ServicesGlobal Translational Medicine ServicesGlobal Early Stage Clinical Development ServicesGlobal Phase II - IV Clinical Development ServicesWhy QPS?
April 18, 2023 Confidential 73
‘helping you navigate your drug all the way across the finish line’
Global Phase II-IV Clinical Research
April 18, 2023 Confidential 74
Global Phase II-IV Clinical Research
Brief Global Overview‘Widely recognized for achieving high-quality study data and high patient enrollment rates, QPS’ site management & monitoring teams bring you years of experience’
Phase I - IV Project and Study ManagementClinical Trial MonitoringClinical Trial Logistics and SuppliesData ManagementBiostatisticsMedical Writing
April 18, 2023 Confidential 76
Global Phase II-IV Clinical Research
Phase II – IV Clinical Study Experience
April 18, 2023 Confidential 77
Phase II67 Studies
Phase III59 Studies
Phase IV63 Studies
N = 189 Studies
Global Phase II-IV Clinical Research
‘Apart from stand-alone clinical research activities, QPS is also able to manage your entire clinical drug development program’
Clinical Consultancy and support throughProject Life CycleDesign of Clinical Program and Individual StudiesQPS will conduct your project according to the protocol with high quality data withintimelines and within budget
Project Management
April 18, 2023 Confidential 79
Global Phase II-IV Clinical Research
Site Management & Monitoring‘Let QPS manage your Clinical Research Activities’
April 18, 2023 Confidential 80
Site Selection, Patient Recruitment and Site Logistics
Site TrainingStudy Reference ManualProtocol/Study MaterialsOne-on-One SessionsTrain-the-Trainer SessionsOnline PresentationsOnline Tutorials for EDC
EDC On-Site MonitoringStudy InitiationInterim VisitsStudy Close Out
Regulatory Document Collection, Review and Submission
Site Audit and/or QualificationPer RequestFor Cause
Global Phase II-IV Clinical Research
‘State-of-the-art clinical trial management and electronic data capture systems enable QPS to deliver first rate data management services’
Streamlined clinical information capabilities between QPS and Investigational Sites/BranchesClinical Database
Paper based CRFeCRF
Fast Data Base Lock
Data Management
April 18, 2023 Confidential 81
Global Phase II-IV Clinical Research
Data Analysis for Late Stage Clinical StudiesSAS ProgrammingExports of Tables, Figures and Listings (TFLs)PK / PD Analysis (including Pop PK)
Pharmacokinetic and statistical consultancyStudy design including optimization of PK sampling and power evaluation of population size enrolledNon-compartmental and compartmental PK modelingPopulation pharmacokineticsStand-alone PK/PD report
‘State-of-the-art clinical trial management and electronic data capture
systems enable QPS to deliver first rate biostatistics services’
Biostatistics
April 18, 2023 Confidential 82
‘QPS can take care of all your medical writing needs’Clinical Study ProtocolInvestigator’s BrochureIMPD (Investigational Medicinal Product Dossier)ICFScientific PublicationsFinal Clinical Report (CTD or eCTD)
Global Phase II-IV Clinical Research
Medical Writing
April 18, 2023 Confidential 83
Global Phase II-IV Clinical Research
Clinical Advantages
Global capabilities yielding significant cost savingsLow turn-over of QPS staff, specifically CRAsAccess to a large network of investigatorsExperienced central management and local expertisePersonal touch of a boutique CRO but with global capabilities
April 18, 2023 Confidential 84
Why QPS?
What sets us apart?‘QPS will help you navigate your way through the complex challenges of the development of your drug….and while navigating your way, you will enjoy having….’
Direct access to QPS’ people's minds!Direct access to key personnelDirect access to vast amounts of drug discovery & development experienceScientific expertise spanning preclinicalwork to drug approval
Direct access to QPS’ people's hearts!EnthusiasmProfessional attitudeFlexibility in meeting client needsFocus on long-term professional customer relationships
Direct access to QPS’ people's hands!Responsive and committed to your timelines Cost effective approach for program development
April 18, 2023 Confidential 85
top related